Accordingly, several studies using pharmacological NRF2 activators suggested a protective role of NRF2 activation against obesity and insulin resistance (Yu et al., 2011; He et al., 2012; Bahadoran et al., 2013). Here, NFE2L2 is linked to Obesity.